Hodgkin Lymphoma in a Case of Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors

• Prif Awduron: Smeeta GAJENDRA (Awdur), Archana SHARMA (Awdur), Rashi SHARMA (Awdur), Sunil Kumar GUPTA (Awdur), Nitin SOOD (Awdur), Ritesh SACHDEV (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Federation of Turkish Pathology Societies, 2019-01-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Chronic myeloid leukemia (CML) is characterized by increased and unregulated proliferation of granulocytic lineage in the bone marrow and presence of these immature myeloid cells in the peripheral blood with presence of Philadelphia (Ph) chromosome. Tyrosine kinase inhibitors are the most important...